Details

Re-evaluation decision RVD2024-02, Bacillus amyloliquefaciens strain MBI 600 and Bacillus subtilis strain QST 713 and their associated end-use products - Canada.ca

Metadata and links for an archived snapshot.

Source
Health Canada
Date
Jan 4, 2026 · edition #6
Timestamp
2026-01-04T19:23:08.089Z
Language
en
ID
461074
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview